Education
About Us
Working with TipRanks
Follow Us
Carl Zeiss Meditec (GB:0DHC)
LSE:0DHC
0DHC Stock Chart & Stats
Day’s Range― - ―
52-Week Range€44.28 - €104.80
Previous CloseN/A
Volume19.84K
Average Volume (3M)25.08K
Market Cap
€4.81B
Enterprise Value€6.91B
Total Cash (Recent Filing)€0.00
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)26.7
Beta1.42
Next Earnings
May 14, 2025EPS Estimate
0.43Last Dividend Ex-Date
Mar 27, 2025Dividend Yield1.06%
Share Statistics
EPS (TTM)0.36
Shares Outstanding89,440,570
10 Day Avg. Volume30,728
30 Day Avg. Volume25,076
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)5.60
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€60.75Price Target Upside3.32% Upside
Rating ConsensusHold
Number of Analyst Covering10
---
Bulls Say, Bears Say
Bulls Say
EarningsCarl Zeiss Meditec released preliminary figures that were a substantial beat on topline and EBITA.
Product ApprovalApproval of Visumax 800 in China should drive better equipment revenue during H2.
Bears Say
Market ConcernsSome worries about summer season pull-forward exist, with concerns about China refractive consumer trends.
TariffsTariff exposure could be a headwind to EBIT, with a worst-case gross headwind of €25m or ~100 bps to margins.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.32%
Mutual Funds
0.01% Other Institutional Investors
94.02% Public Companies and
Individual Investors
0DHC FAQ
What was Carl Zeiss Meditec’s price range in the past 12 months?
Carl Zeiss Meditec lowest share price was €44.28 and its highest was €104.80 in the past 12 months.
What is Carl Zeiss Meditec’s market cap?
Carl Zeiss Meditec’s market cap is €4.81B.
When is Carl Zeiss Meditec’s upcoming earnings report date?
Carl Zeiss Meditec’s upcoming earnings report date is May 14, 2025 which is in 20 days.
How were Carl Zeiss Meditec’s earnings last quarter?
Carl Zeiss Meditec released its earnings results on Feb 12, 2025. The company reported €0.36 earnings per share for the quarter, beating the consensus estimate of €0.294 by €0.066.
Is Carl Zeiss Meditec overvalued?
According to Wall Street analysts Carl Zeiss Meditec’s price is currently Undervalued.
Does Carl Zeiss Meditec pay dividends?
Carl Zeiss Meditec pays a Annually dividend of €0.6 which represents an annual dividend yield of 1.06%. See more information on Carl Zeiss Meditec dividends here
What is Carl Zeiss Meditec’s EPS estimate?
Carl Zeiss Meditec’s EPS estimate is 0.43.
How many shares outstanding does Carl Zeiss Meditec have?
Carl Zeiss Meditec has 89,440,570 shares outstanding.
What happened to Carl Zeiss Meditec’s price movement after its last earnings report?
Carl Zeiss Meditec reported an EPS of €0.36 in its last earnings report, beating expectations of €0.294. Following the earnings report the stock price went down -8.416%.
Which hedge fund is a major shareholder of Carl Zeiss Meditec?
Currently, no hedge funds are holding shares in GB:0DHC
---
Carl Zeiss Meditec Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€60.75 (3.32% Upside)
€60.75 (3.32% Upside)
Blogger Sentiment
Bullish
GB:0DHC Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-44.18%
12-Months-Change
Fundamentals
Return on Equity
8.51%
Trailing 12-Months
Asset Growth
13.22%
Trailing 12-Months
Company Description
Carl Zeiss Meditec
Carl Zeiss Meditec is a Jena, Germany-based manufacturer of ophthalmic devices, such as intraocular lenses, diagnostic equipment, and refractive laser systems, along with optical equipment for microsurgical applications such as neurosurgery. The company now reports in two primary segments, ophthalmic devices (73% of fiscal 2018 revenue) and microsurgery (27%). From a geographic perspective, the firm has a balanced mix of global sales, with 30% derived from Europe, the Middle East, and Africa, 32% from the Americas, and 38% from Asia-Pacific.
---
0DHC Stock 12 Month Forecast
Average Price Target
€60.75
▲(3.32% Upside)
Technical Analysis
Qiagen
―
Fresenius Medical Care AG & Co. KGaA
―
RHON-KLINIKUM AG
―
Sartorius
―
Siemens Healthineers AG
―
Best Analysts Covering 0DHC
1 Year
1 Year Success Rate
8/13 ratings generated profit
1 Year Average Return
+12.87%
reiterated a sell rating 10 days ago
Copying Anchal Verma's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +12.87% per trade.
---